Several studies showed an association of systemic biomarkers of inflammation, such as C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α), with progression of CKD and with higher risk for morbidity and mortality, particularly due to cardiovascular (CV) events [3–6]. Here, IL6 is linked to chronic kidney disease.